首页> 美国卫生研究院文献>Molecular Medicine Reports >Violacein induces p44/42 mitogen-activated protein kinase-mediated solid tumor cell death and inhibits tumor cell migration
【2h】

Violacein induces p44/42 mitogen-activated protein kinase-mediated solid tumor cell death and inhibits tumor cell migration

机译:紫堇素诱导p44 / 42丝裂原活化的蛋白激酶介导的实体肿瘤细胞死亡并抑制肿瘤细胞迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microbial secondary metabolites have emerged as alternative novel drugs for the treatment of human cancers. Violacein, a purple pigment produced by Chromobacterium violaceum, was investigated in the present study for its anti-tumor properties in tumor cell lines. Clinically applicable concentrations of violacein were demonstrated to inhibit the proliferative capacity of tumor cell lines according to a crystal violet proliferation assay. The underlying mechanism was the promotion of apoptotic cell death, as indicated by poly(ADP ribose) polymerase cleavage and p44/42 mitogen-activated protein kinase signaling determined by western blot analysis. Collectively, this provided mechanistic evidence that violacein elicits extracellular-signal regulated kinase-induced apoptosis via the intrinsic pathway. The anti-malignant properties of violacein in the present study were further demonstrated by its inhibitory effects on brain tumor cell migration, specifically glioblastomas, one of the most invasive and therapeutically resistant neoplasms in the clinic. Additionally, solid tumors examined in the present study displayed differential cellular responses and sensitivities to violacein as observed by morphologically induced cellular changes that contributed to its anti-migratory properties. In conclusion, violacein is a novel natural product with the potential to kill several types of human tumor cell lines, as well as prevent disease recurrence by antagonizing cellular processes that contribute to metastatic invasion.
机译:微生物次生代谢产物已作为治疗人类癌症的替代新药出现。在本研究中,对紫堇杆菌(一种由紫杆菌杆菌产生的紫色颜料)的抗肿瘤特性进行了研究。根据结晶紫增殖测定法,证明了临床上可应用的浓度的紫堇青素抑制肿瘤细胞系的增殖能力。如通过蛋白质印迹分析确定的聚(ADP核糖)聚合酶切割和p44 / 42丝裂原活化的蛋白激酶信号表明的,潜在的机制是促进凋亡细胞死亡。总的来说,这提供了机械证据,证明紫丁香素通过内在途径引起细胞外信号调节激酶诱导的细胞凋亡。紫精素对脑肿瘤细胞迁移的抑制作用进一步证明了紫精的抗恶性特性,尤其是胶质母细胞瘤,这是临床上最具侵入性和治疗性的肿瘤之一。此外,在本研究中检查的实体瘤显示出不同的细胞反应和对紫精的敏感性,这是通过形态学诱导的细胞变化(有助于其抗迁移特性)观察到的。总之,紫堇青素是一种新型的天然产物,具有杀死多种类型的人类肿瘤细胞系的潜力,并通过拮抗有助于转移性侵袭的细胞过程来预防疾病复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号